Epiphytic fungi isolated from Kenyan coastal brown algae were identified morphologically and by ITS sequencing, confirming taxa in genera known for secondary metabolite production. Nine potent, broadly active isolates were selected for further testing against multidrug-resistant ESKAPE pathogens, including Enterobacter cloacae, Acinetobacter baumannii, Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
Both methanolic and ethyl acetate extracts inhibited growth, yielding zones of inhibition from 14 to 30.4 mm. MIC and MBC values reached as low as 0.039 mg/mL and 0.156 mg/mL, respectively, with notably strong activity observed for extracts from Alternaria spp.
(Dib-4), Curvularia spp. (Dib-3), and Penicillium spp.
(Sac-12). SEM revealed bacterial cell envelope disruption, including membrane blebbing, collapse, and lysis, suggesting a membrane-directed mechanism of action.
GC–MS profiling indicated the presence of multiple bioactive metabolites. Some isolates showed only moderate or selective activity.
The data indicate brown seaweed–associated fungi as a potential reservoir of antibacterial compounds with activity against multidrug-resistant pathogens, and solvent choice influenced metabolite recovery.
(Dib-4), Curvularia spp.
(Dib-3), and Penicillium spp.
(Sac-12).